Hyper Pigmentation Global Clinical Trials Review, H1, 2014 Available At MarketResearchReports.biz

Hyper Pigmentation Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, Hyper Pigmentation Global Clinical Trials Review, H1, 2014" provides data on the Hyper Pigmentation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyper Pigmentation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyper Pigmentation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Browse Complete report with TOC : 
http://www.marketresearchreports.biz/analysis-details/hyper-pigmentation-global-clinical-trials-review-h1-2014 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/188577 

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyper Pigmentation 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Hyper Pigmentation Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Hyper Pigmentation 28
Jul 12, 2011: Azelaic Acid Gel Improves Post-Inflammatory Hyperpigmentation In Acne Patients With Dark Skin Types 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Kasiak Research Pvt. Ltd. 29
Clinical Trial Overview of Kasiak Research Pvt. Ltd. 29
Johnson & Johnson 30
Clinical Trial Overview of Johnson & Johnson 30
Bayer AG 31

Visit Analysis Report @ 
http://www.marketresearchreports.biz/analysis/188577 

Clinical Trial Overview of Bayer AG 31
Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
Clinical Trial Overview of Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
nPharmakon 33
Clinical Trial Overview of nPharmakon 33
Glenmark Pharmaceuticals Ltd. 34
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 34
Galderma S.A. 35
Clinical Trial Overview of Galderma S.A. 35
Clinical Trial Overview of Top Institutes / Government 36
The Indian Association of Dermatologists, Venereologists and Leprologists 36
Clinical Trial Overview of The Indian Association of Dermatologists, Venereologists and Leprologists 36
Tabriz University of Medical Sciences 37
Clinical Trial Overview of Tabriz University of Medical Sciences 37
Callender Center for Clinical Research 38
Clinical Trial Overview of Callender Center for Clinical Research 38
Tohoku University Graduate School of Medicine, Department Of Surgery 39
Clinical Trial Overview of Tohoku University Graduate School of Medicine, Department Of Surgery 39
Brazilian Center for Studies in Dermatology 40


Contact US:    
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

meet us on:
facebook: http://facebook.com/marketresearchreports.biz
twitter: http://twitter.com/mrrbizreport/

Building And Construction Plastics Market For Pipes & Ducts, Insulation, Door Fittingsand Other Applications

Building And Construction Plastics Market  For Pipes & Ducts, Insulation, Door Fittingsand Other Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

The report covers forecast and analysis for the building & construction plastics market on a global and regional level. The study provides historical data of 2012 along with a forecast from 2013 to 2019 based on both volumes (kilo tons) and revenue (USD million). The study includes drivers and restraints for the building & construction plastics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the building & construction plastics market on a global and regional level.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/building-and-construction-plastics-market-pvc-ps-acrylics-pu-tpe-composite-materials-and-others-for-pipes-and-ducts-insulation-door-fittingsand-other-applications-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

In order to give the users of this report a comprehensive view on the building & construction plastics Market, we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the building & construction plastics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, general attractiveness and company market share.

The study provides a decisive view on the building & construction plastics market by segmenting the market based on product types and applications. All the product and application segments have been analyzed based on present and future trends and the CAGR for the market is estimated between2013 and2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW). This segmentation includes demand for individual applications in all the regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BASF SE, Borealis AG, DuPont, The Dow Chemical Company, Solvay SA, Arkema SA and PetroChina Ltd. among others. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments. The market has been segmented as below:

Building & Construction Plastics Market: Product Segment Analysis

• Polyvinyl chloride (PVC)
• Polystyrene (PS)
• Acrylics
• Polyurethanes (PU)
• Thermoplastics Elastomers (TPE)
• Composite materials
• Others (Includes polypropylene, polycarbonates, etc.)

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186977 

Building & Construction Plastics Market: Application Analysis

• Pipes & Ducts
• Insulation
• Door Fittings
• Others (Including roofing, cladding, water proofing, etc.)

Building & Construction Plastics Market: Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

Also Visit@ http://thaineuro.org/building-and-construction-plastics-market-pvc-ps-acrylics-pu-tpe-composite-materials-and-others-for-pipes-ducts-insulation-door-fittingsand/


Table of Content

Chapter 1 Preface
1.1 Research description
1.2 Market segmentation
1.2.1 Global building & construction plastics market segmentation, product segment, application and region
1.3 Research scope
1.4 Research methodology
1.4.1 Assumptions
1.4.2 Abbreviations



Chapter 2 Executive Summary
2.1 Global building & construction plastics market, 2012 – 2019 (Kilo Tons) (USD Million)

Chapter 3 Building & Construction Plastics - Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.3 Market drivers
3.3.1 Growing building and construction industry
3.3.2 Huge consumption of plastics
3.4 Market restraints
3.4.1 Volatility in crude oil prices
3.4.2 Environmental regulations
3.5 Market opportunities
3.5.1 Growing demand of green building
3.5.2 Rising bio plastics market
3.6 Porter’s five forces analysis
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threat of new entrants
3.6.4 Threat from substitutes
3.6.5 Degree of competition
3.7 Building & construction plastics: Market attractiveness analysis
3.7.1 Global building & construction plastics: Market attractiveness, analysis
3.8 Building & construction plastics: Company market share analysis
3.8.1 Global building & construction plastics: Company market share analysis


Contact US:    
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, SiRNA Transplant Solution And Others, And By Preservation Techniques

    
Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved, type of preservation techniques used and the major geographic markets. The global market for organ preservation solutions has been segmented into nine major solutions that include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). On the basis of preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques).

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/organ-preservation-solutions-market-by-solutions-viaspan-custodiol-htk-renograf-hypothermosol-perfadex-lifor-hbs-solution-sirna-transplant-solution-and-others-and-by-preservation-techniques--hypothermic-perfusion-preservation-static-c 

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for each solution type, technique type and geographic region. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments.

Also Visit @ http://www.prlog.org/12280289-organ-preservation-solutions-market-viaspan-custodiol-htk-renograf-hypothermosol.html

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. This section also covers a market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global organ preservation solutions market. Market share (%) for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. Also, the report includes company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation Solutions Market, by Solution 

• Viaspan
• Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• Human bioSystem (HBS) Solution
• siRNA Transplant Solutions
• Others

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186971 

Organ Preservation Solutions Market, by Preservation Technique

• Hypothermic Perfusion Preservation (HPP)
• Static Cold Storage (SCS)
• Others

Organ Preservation Solutions Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)


To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/186971 


Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Aging global population
3.2.1.1 Global rate of aging population
3.2.2 Technological advancements
3.2.3 Increasing reimbursement scenario
3.2.4 Increase in per capita healthcare expenditure


Contact US:    
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

blog: Latest Market Research Reports

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description

Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be driven by a rising treatment population and the continued uptake of biologics. Biologics will continue to drive market growth despite leading brands Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) losing patent protection in most of the major markets over the forecast period. Although the market will suffer revenue losses as a result of sales erosion from biosimilar competitors, this will be offset by the emergence of novel therapies. Most notably, these include monoclonal antibodies secukinumab, ixekizumab and brodalumab, which are currently being developed by Alcon (Novartis subsidiary), Eli Lilly and Amgen, respectively.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/186872 

Scope

• An introduction to psoriasis, which includes symptoms, epidemiology, etiology, pathophysiology, diagnosis and treatment
• Analysis of the major systemic therapies in the current psoriasis marketed landscape
• Analysis of the pipeline for psoriasis, which includes a breakdown of pipeline molecules by phase of development, molecule type, molecular target and novelty. Psoriasis clinical trials are analyzed by size, duration and failure rates, and a comparative analysis of the most promising systemic pipeline molecules is also provided.
• Forecast projections for the systemic psoriasis market to 2020. Analysis is provided for the global market and each of the eight major markets. The forecast incorporates projected, low and high variance scenarios based on treatment usage patterns and annual therapy costs in each of the major markets.
• Analysis of strategic consolidations, including co-development and licensing deals, within the psoriasis indication

Reasons to Buy

• Understand the current systemic psoriasis marketed products landscape and recognize the dominant therapeutic agents and pharmaceutical players involved
• Identify trends and developments within the psoriasis pipeline and consider how the future competitive environment will be impacted
• Consider market opportunities and potential risks by examining the psoriasis clinical trial landscape in relation to industry averages
• Observe projections for treatment usage patterns, annual therapy costs and market growth in the eight major markets and understand reasons for variance in projected patterns of growth in the eight major markets


To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186872

Table of Content

1 Table of Contents 1
1.1 List of Tables 4
1.2 List of Figures 5

2 Executive Summary 6
2.1 Changes to Treatment Usage Patterns will Drive Market Growth 6
2.2 Biologics to Gain Prominence as Promising Novel Drugs Enter the Market 6

3 Introduction 7
3.1 Overview 7
3.2 Epidemiology 8
3.3 Etiology, Co-morbidities and Risk Factors 9
3.3.1 Genetics 9
3.3.2 Psoriatic Arthritis 9
3.3.3 Mental Health Disorders 10
3.3.4 Metabolic Syndrome, Smoking, Diet and Alcohol Consumption 10
3.3.5 Infections 10
3.3.6 Köebner Phenomenon 11
3.3.7 Other Immune-mediated Diseases 11
3.4 Pathophysiology 11
3.5 Diagnosis 12
3.6 Treatment Options 12
3.6.1 Pharmacological Therapies 13
3.6.2 Non-pharmacological Therapies 14
3.6.3 Combination and Rotational Therapies 14
3.6.4 Quality of Life Assessments 15
3.7 Summary 15
3.8 GBI Research Report Guidance 15

4 Marketed Products 16
4.1 Overview 16
4.2 Methotrexate-based Products 16
4.3 Sandimmune/Neoral (cyclosporine/modified cyclosporine) – Novartis 17
4.4 Soriatane (acitretin) – Steifel Laboratories 18
4.5 Fumaderm (dimethyl fumarate and ethyl fumarate) – Biogen Idec 19
4.6 Humira (adalimumab) – Abbvie Inc. 20
4.7 Enbrel (etanercept) – Amgen Inc. 21
4.8 Remicade (infliximab) – Janssen Biotech 22
4.9 Stelara (ustekinumab) – Janssen Biotech 23
4.10 Marketed Products Heat Map 24


To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis-details/systemic-psoriasis-therapeutics-in-major-developed-markets-to-2020-continued-uptake-of-biologics-and-novel-pipeline-drugs-to-drive-growth-description


5 Pipeline 27
5.1 Overview 27
5.2 Pipeline Size and Distribution by Phase, Molecule Type and Program Type 28
5.3 Pipeline Distribution by Molecular Target 30
5.4 Clinical Trial Landscape 32
5.4.1 Clinical Trial Duration 32
5.4.2 Clinical Trial Size 36
5.5 Clinical trial failure rates 40
5.6 Primary and Secondary Endpoints 41
5.7 Summary of Psoriasis Clinical Trials 43
5.8 Promising pipeline molecules 43
5.8.1 Ixekizumab – Eli Lilly 43
5.8.2 Xeljanz (tofacitinib) – Pfizer 44
5.8.3 Brodalumab – Amgen 45
5.8.4 Apremilast – Celgene 46
5.8.5 Secukinumab – Alcon 47
5.9 Heat Map for Pipeline Products 47

6 Market Forecast to 2020 52
6.1 Overview 52
6.2 Global Market 52
6.3 North America 55
6.3.1 Treatment Usage Patterns 55
6.3.2 Annual Cost of Treatment 56
6.3.3 Market Size 58
6.4 Top Five EU Markets 59
6.4.1 Treatment Usage Patterns 59
6.4.2 Annual Cost of Treatment 60
6.4.3 Market Size 61
6.5 Japan 62
6.5.1 Treatment Usage Patterns 62
6.5.2 Annual Cost of Treatment 63
6.5.3 Market Size 64
6.6 Drivers and Barriers for the Systemic Psoriasis Therapeutics Market 65
6.6.1 Drivers 65
6.6.2 Barriers 65

7 Co-development and Licensing deals 67
7.1 Co-development Deals 67
7.1.1 Abbvie Enters into Co-development Agreement with Biotest for Tregalizumab 70
7.1.2 Lycera Enters into Research Agreement with Merck & Co. 70
7.1.3 LEO Pharma Enters into Research Agreement with 4SC Discovery for Inflammatory Skin Diseases 70
7.1.4 Amgen Enters into Co-Development Agreement with AstraZeneca for Five Human Monoclonal Antibodies Including Brodalumab 70
7.2 Licensing Deals 72
7.2.1 Leo Pharma Enters into Licensing Agreement with Virobay for Psoriasis Drug 75
7.2.2 Foamix Enters into Licensing Agreement with Dr. Reddy\'s Labs 75
7.2.3 Cipher Pharma Enters into Licensing Agreement with IBSA Institut Biochimique for Betesil Patch 75
7.2.4 Phenex Pharma Enters into Licensing Agreement with Janssen Biotech for Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 75

8 Appendix 76



Contact Us:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Web: http://www.marketresearchreports.biz/

Blog: http://articlesnarticles.blogspot.com/

Blood Gas And Electrolyte Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Blood Gas And Electrolyte Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Blood gas and electrolyte (or Blood gas analyzer) analyzers are widely used in blood testing. Blood gas analyzer measures concentration of hydrogen ions which is a measure of acidity, partial pressure of carbon dioxide to access efficiency of its elimination from the body, and partial pressure of oxygen to access the efficiency in oxygen absorption. It also measures electrolyte in the blood such as sodium, calcium, chloride ions and bicarbonate ions. The concentration of oxygen, carbon dioxide and other electrolytes along with pH are indicators for diabetes, hemorrhage, drug overdose, shock and other conditions. They can also be used in studying lung, kidney and metabolic disorders in patients. Due to the wide scope of application, they are frequently used in hospitals and laboratories for testing purposes.

Browse Complete report with TOC : 
http://www.marketresearchreports.biz/analysis/186349

The blood gas and electrolyte analyzer market can be segmented as follows:

1. Bench-top analyzer
2. Portable analyzer

The market for blood gas analyzers is mainly driven by the risingnumber of patients being treated annually in hospitals especially intensive care units and emergency departments. Manufacturers are now focusing on making the devices more user friendly and automated so as to save time and increase accuracy, by eliminating manual errors. There are also additions being made in the devices so that a single sample can give an analysis of various parameters such as body electrolyte concentration, blood urea nitrogen, creatinine and others. This has expanded the scope of application of the devices and hence the market as well. Device miniaturization, ease of use, analysis of various parameters and requirement of small sample are some of the product features prominent for the market growth. Blood sampling from venous blood is more convenient as it is a minimally invasive process and less painful. Hence researchers are trying to explore possibilities in increasing efficiency for venous blood testing.

Blood gas and electrolyte analyzer market is quite mature and saturated with players such as Siemens, Roche, Medica, Erba, Nova Stat, Bayer,Radiometer Medical, Samsung Medison, Opti Medical Systems, Inc., Edan Instruments, Inc., Convergent Technologies and others. Various companies such as GMI, Dalko Diagnostics and Inter Bio-Lab, also offer refurbished blood gas and electrolyte analyzers.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

• North America
• Asia Pacific
• Europe
• Rest of the World

To Download Sample Report Visit @ 
http://www.marketresearchreports.biz/sample/toc/186349

This report provides comprehensive analysis of

• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years

Also Visit Link: Blood Gas And Electrolyte Analyzers Market

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified SWOT analysis of major market segments


  Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Nonwoven Materials & Products (Polypropylene, Polyester, Nylon And Others) Market For Disposable And Durable Applications

Nonwoven Materials & Products (Polypropylene, Polyester, Nylon And Others) Market For Disposable And Durable Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

The report covers forecast and analysis for the nonwoven materials and productsmarket on a global and regional level. The demand forecast is done based on volumes (kilo tons) and revenue (USD million) for the period ranging from 2013 to 2019. The study includes the drivers and restraints for the nonwoven materials and productsmarket along with the impact they have on the demand over the forecast period. Moreover, the report includes the study of the opportunities available in the nonwoven materials and productsmarket on a global and regional level.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/nonwoven-materials-and-products-market-global-industry-analysis-size-market-share-growth-trends-and-forecast-2012-2018

To give the users of this report a comprehensive view on the nonwoven materials and productsmarket, we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of the Porters five forces model for the nonwoven materials and products market has also been included. The study encompasses a market attractiveness analysis, wherein the applications are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the nonwoven materials and productsmarket by segmenting the market based on its product segments and applications. All the product and application segments have been analyzed based on present and future trends and the market is estimated from 2013 to 2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the world (RoW). This segment includes the demand for individual applications and product segments in all the regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Freudenberg SE, Ahlstrom Incorporation, Du Pont, Kimberly-Clark Corporation, Polymer Group Incorporation, and Asahi Kasei Corporation among others.The company profiles include attributes like company overview, financial overview, business strategy, SWOT analysis and recent developments.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/166024 

Nonwoven Materials & Products Market: Product Segment Analysis

• Polypropylene
• Polyester
• Nylon
• Others (Cellulosics, bio-component fibers, nano-fibers, etc.)

Nonwoven Materials & Products Market: Application Analysis

• Disposables (Medical products, disposable wipes, filters, etc.)
• Durables (Wall coverings, home furnishings, geotextiles, etc.)

Nonwoven Materials & Products Market: Regional Analysis

• North America
• Europe
• Asia Pacific
• RoW (South America, Africa and Middle East)


To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/166024 


Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
1.2.1 Global nonwoven materials and products market segmentation, application and region
1.3 Research scope
1.3.1 Assumptions
1.4 Research methodology

Also Visit At : Nonwoven Materials & Products Market (Polypropylene, Polyester, Nylon And Others)

Chapter 2 Executive Summary
2.1 Global nonwoven materials and products market, 2012 - 2019 (Kilo Tons) (USD Million)

Chapter 3 Market Overview
3.1 Introduction
3.2 Value chain analysis
3.2.1 Value chain analysis of the global nonwoven materials and products market
3.3 Market drivers
3.3.1 Rising demand for disposable medical supplies
3.3.1.1 Global disposable medical supplies market revenue, 2012 – 2019, (USD Billion)
3.3.2 Growing geotextiles industry
3.3.2.1 Global geotextiles market revenue, 2012 – 2019, (USD Billion)
3.4 Restraints
3.4.1 Health risks associated with nonwoven fabrics
3.4.2 Stagnancy in developed markets
3.5 Opportunity
3.5.1 Increasing use of durable items in construction industry
3.5.1.1 Global construction market revenue, 2012 – 2019, (USD Billion)
3.6 Porter’s five forces analysis
3.6.1 Porter’s five forces analysis of the global nonwoven materials and products market
3.6.2 Bargaining power of suppliers
3.6.3 Bargaining power of buyers
3.6.4 Threat from new entrants
3.6.5 Threat from substitutes
3.6.6 Degree of competition
3.7 Market attractiveness analysis
3.7.1 Global nonwoven materials and products market attractiveness, by product segment, 2012
3.8 Company market share analysis
3.8.1 Global nonwoven materials and products market share, by company, 2012

Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz